ABDDF yields 0.73% · PFE yields 6.20%● Live data
📍 ABDDF pulled ahead of the other in Year 1
Combined, ABDDF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ABDDF + PFE for your $10,000?
AB Dynamics plc, through its subsidiaries, engages in the design, development, manufacture, and supply of vehicle test and development systems, and verification products and services for advanced driver assistance systems (ADAS), autonomous vehicle technology, and vehicle dynamics in the United Kingdom, Germany, the United States of America, China, Japan, Singapore, and internationally. The company offers advanced vehicle testing solutions from physical proving ground automation to large scale virtual testing in simulation; rFpro, a simulation environment for the automotive and motorsport industries; and full-scale track testing services, including ADAS and vehicle dynamics tests, along with applied research, human factors, and simulation. It also provides automotive testing services comprising evaluations of ADAS systems, infotainment, connectivity, electric vehicle performance and charging, and other associated functions; and retrofit solutions that enable the automation of conventional vehicle fleets rapidly and cost-effectively. In addition, the company creates and deploys a range of Driver-in-the-Loop (DIL) simulators for all types of vehicles, driving scenarios, experiments, and product development aims; supplies end-to-end simulation solutions, such as hardware, software, application consultancy, training, and aftermarket support; and advanced vehicle testing solutions from physical proving ground automation to virtual testing in simulation. Its products are used to evaluate vehicle dynamics, noise, vibration, and harshness and autonomy for a range of applications comprise conventional vehicles, motorsport, and automated/autonomous vehicles. The company was founded in 1982 and is headquartered in Bradford-on-Avon, the United Kingdom.
Full ABDDF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.